Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
NCT05294666
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
89
Enrollment
OTHER
Sponsor class
Conditions
Graft Versus Host Disease in Eye
Interventions
DRUG:
Cyclosporine
DRUG:
tacrolimus
Sponsor
Peking University Third Hospital